# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-21-000713
Filing Date
2021-01-11
Accepted
2021-01-08 21:01:27
Documents
34
Period of Report
2021-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | life-8k_20210108.htm | 8-K | 37879
2 | EX-99.1 | life-ex991_7.htm | EX-99.1 | 23630
3 | GRAPHIC | slide-5x3zeunzjdm.jpg | GRAPHIC | 59955
4 | GRAPHIC | slide-nf3zt5db1ae.jpg | GRAPHIC | 42803
5 | GRAPHIC | slide-ggtaucarb2k.jpg | GRAPHIC | 37328
6 | GRAPHIC | slide-bgl10zf300n.jpg | GRAPHIC | 24211
7 | GRAPHIC | slide-5q4zhuf3yez.jpg | GRAPHIC | 131869
8 | GRAPHIC | slide-ptagttzmcot.jpg | GRAPHIC | 87891
9 | GRAPHIC | slide-ulc5ruovdcg.jpg | GRAPHIC | 64704
10 | GRAPHIC | slide-hgbz4s3n33s.jpg | GRAPHIC | 55832
11 | GRAPHIC | slide-0l2em4vns0i.jpg | GRAPHIC | 28152
12 | GRAPHIC | slide-jw0xtq2g00n.jpg | GRAPHIC | 25719
13 | GRAPHIC | slide-cxkxpmdi3dx.jpg | GRAPHIC | 27172
14 | GRAPHIC | slide-epllum444ef.jpg | GRAPHIC | 87664
15 | GRAPHIC | slide-fns2cefew1n.jpg | GRAPHIC | 48238
16 | GRAPHIC | slide-f1clgve1g3a.jpg | GRAPHIC | 41573
17 | GRAPHIC | slide-oudmlstvtgh.jpg | GRAPHIC | 59434
18 | GRAPHIC | slide-tlfaghark43.jpg | GRAPHIC | 72972
19 | GRAPHIC | slide-rthdlyz5bzt.jpg | GRAPHIC | 64167
20 | GRAPHIC | slide-ceboemhqgne.jpg | GRAPHIC | 63985
21 | GRAPHIC | slide-n1ik2ld05jr.jpg | GRAPHIC | 57334
22 | GRAPHIC | slide-zhadqgibv35.jpg | GRAPHIC | 62572
23 | GRAPHIC | slide-hrcbckjotvi.jpg | GRAPHIC | 77521
24 | GRAPHIC | slide-uh1yvalnlv0.jpg | GRAPHIC | 25882
25 | GRAPHIC | slide-3kbvf3seazh.jpg | GRAPHIC | 61915
26 | GRAPHIC | slide-yx51v5zw53m.jpg | GRAPHIC | 53082
27 | GRAPHIC | slide-ahhpls3trnh.jpg | GRAPHIC | 99284
28 | GRAPHIC | slide-ervj5n30y42.jpg | GRAPHIC | 23384
29 | GRAPHIC | slide-q0opefh3iha.jpg | GRAPHIC | 28788
30 | GRAPHIC | slide-i3prd5diooi.jpg | GRAPHIC | 55540
31 | GRAPHIC | slide-1anknqut2k5.jpg | GRAPHIC | 71840
32 | GRAPHIC | slide-dgc2kwdj1zo.jpg | GRAPHIC | 41985
33 | GRAPHIC | slide-2zojbfdpudz.jpg | GRAPHIC | 58400
34 | GRAPHIC | slide-3p5aub0fagb.jpg | GRAPHIC | 60988
| Complete submission text file | 0001564590-21-000713.txt |  | 2549065

Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 21518899
SIC: 2836 Biological Products, (No Diagnostic Substances)